Evidence map›Paper›PMID 33568625›Full record

ArticleCell death & disease2021

circST6GALNAC6 suppresses bladder cancer metastasis by sponging miR-200a-3p to modulate the STMN1/EMT axis.

Shuo Tan, Ye Kang, Hu Li, Hai-Qing He, Long Zheng, Shui-Qing Wu, Kai Ai, Lei Zhang, Ran Xu, Xuan-Zhi Zhang and 2 more

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 43 citations in OpenAlex.

  1. Identification ofMolecular medicine reports · 2026
    Article
  2. [Research progress in the role of STMN1 in tumor].Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2025
    Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Frontiers in immunology · 2024
    Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Shuo TanDepartment of Urology, the Second Xiangya Hospital of Central South University, Changsha, Hunan Province, P R China.
Ye KangDepartment of Urology, the Second Xiangya Hospital of Central South University, Changsha, Hunan Province, P R China.
Hu LiDepartment of Urology, the Second Xiangya Hospital of Central South University, Changsha, Hunan Province, P R China.
Hai-Qing HeDepartment of Urology, the Second Xiangya Hospital of Central South University, Changsha, Hunan Province, P R China.
Long ZhengDepartment of Urology, An Xiang Xian People's Hospital, Anxiang, Hunan Province, P R China.
Shui-Qing WuDepartment of Urology, the Second Xiangya Hospital of Central South University, Changsha, Hunan Province, P R China.
Kai AiDepartment of Urology, the Second Xiangya Hospital of Central South University, Changsha, Hunan Province, P R China.
Lei ZhangDepartment of Urology, the Second Xiangya Hospital of Central South University, Changsha, Hunan Province, P R China.
Ran XuDepartment of Urology, the Second Xiangya Hospital of Central South University, Changsha, Hunan Province, P R China.
Xuan-Zhi ZhangDepartment of Urology, the Second Xiangya Hospital of Central South University, Changsha, Hunan Province, P R China.
Xiao-Kun ZhaoDepartment of Urology, the Second Xiangya Hospital of Central South University, Changsha, Hunan Province, P R China.
Xuan ZhuDepartment of Urology, the Second Xiangya Hospital of Central South University, Changsha, Hunan Province, P R China. zhuxuan@csu.edu.cn.
Central South University · CNSecond Xiangya Hospital of Central South University · CNXiangya Hospital Central South University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bladder cancer (BCa) is an aggressive malignancy because of its distant metastasis and high recurrence rate. Circular RNAs (circRNAs) exert critical regulatory functions in cancer progression. However, the expression patterns and roles of circRNAs in BCa have not been well investigated. In this study, we first screened circRNA expression profiles using a circRNA microarray of paired BCa and normal tissues, and the expression of circST6GALNAC6 was confirmed by qRT-PCR and fluorescence in situ hybridization (FISH). MTT, colony formation and Transwell assays were performed to measure cell proliferation, migration and invasion. We investigated the regulatory effect of circST6GALNAC6 on miRNA and its target genes to explore the potential regulatory mechanisms of circST6GALNAC6 by chromatin immunoprecipitation (ChIP), RNA immunoprecipitation (RIP), MS2-tagged RNA affinity purification (MS2-TRAP), immunofluorescence (IF) and dual luciferase activity assays. A nude mouse xenograft model was used to examine the functions of circST6GALNAC6/STMN1 in tumour metastasis in vivo. We found that 881 circRNAs were significantly dysregulated in BCa tissues compared to normal tissues. circST6GALNAC6(hsa_circ_0088708) was downregulated in BCa tissues and cells. Overexpression of circST6GALNAC6 effectively inhibited the cell proliferation, migration, invasion and epithelial-mesenchymal transition (EMT) in vitro and suppressed BCa metastasis in vivo. Mechanistically, we showed that the SP1 transcription factor, which binds to the circST6GALNAC6 mRNA transcript, activates circST6GALNAC6 transcription. Next, we verified that circST6GALNAC6 serves as a sponge that directly binds miR-200a-3p to regulate stathmin (STMN1) expression. Furthermore, we found that STMN1 is involved in circST6GALNAC6/miR-200a-3p axis-regulated BCa EMT and metastasis. Thus, our findings indicate an important underlying mechanism in BCa metastasis by which SP1-induced circST6GALNAC6 sponges miR-200a-3p to promote STMN1/EMT signalling. This mechanism could provide pivotal potential prognostic biomarkers and therapeutic targets for BCa.

Indexed as

Cell MovementEpithelial-Mesenchymal TransitionAnimalsCell Line, TumorCell ProliferationGene Expression Regulation, NeoplasticHumansMiceMice, NudeMicroRNAsNeoplasm InvasivenessRNA, CircularSignal TransductionSp1 Transcription FactorStathminUrinary Bladder NeoplasmsMicroRNAsMIRN200 microRNA, humanRNA, CircularSP1 protein, humanSp1 Transcription FactorStathminSTMN1 protein, human

Identifiers

PMID33568625
PMCPMC7876104
OpenAlexW3126623138

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.